CHANTILLY, Va., Jan. 7, 2020 /PRNewswire/
-- Perspecta Inc. (NYSE: PRSP), a leading U.S.
government services provider, in partnership with PRA Health
Sciences (NASDAQ: PRAH), a leading contract research organization
(CRO) and health sciences company, today announced the
successful launch of the Software as a Service (SaaS) recruitment,
enrollment, engagement and feedback (REEF) solution the company
delivered to the U.S. Department of Veterans Affairs (VA) to meet
the modernization needs of the agency's Million Veteran Program
(MVP).
MVP is a national, voluntary research program funded by the VA
Office of Research and Development. The goal of MVP is to partner
with veterans who receive care in the VA health care system to
study how genes affect health. To do this, MVP is building one of
the world's largest medical databases by safely collecting blood
samples and health information from more than one million veteran
volunteers.
Officially known as MVP Online, the online application was built
by Perspecta on Clinical6, PRA's SaaS mobile clinical trial
platform for patient enrollment, engagement and data collection.
MVP Online will enable veterans to find additional information
about the program, read testimonials, enroll and electronically
consent into the program, complete surveys, and generally replace
the existing paper processes through a single website. MVP Online
will also allow the VA to better engage, recruit and increase
retention in the MVP program.
"While it is always gratifying to see our hard work come to
fruition—seeing the potential reach and positive impact of our work
is most fulfilling," said Mac
Curtis, president and chief executive officer, Perspecta.
"MVP Online will be an incredibly useful tool for the VA today, but
will also serve as a platform to allow current veterans to help
transform health care for future generations of veterans to come.
We are proud to support the VA in their continuous endeavor to
support the men and women of the armed forces who have selflessly
served our nation."
"The MVP Online program and the data coming from the program has
the chance to drastically improve the health and wellbeing of our
country's veterans," said Kent
Thoelke, chief scientific officer and executive vice
president at PRA Health Sciences. "As health care continues to
evolve, it is essential that we focus on impactful ways to engage
with veterans digitally from their homes or anywhere in the world,
so they can enroll in research faster, stay engaged with their
caregivers and get better overall treatment."
The contract was originally awarded to Perspecta Enterprise
Services in 2017. During the two-year collaboration, Perspecta and
PRA provided the VA with the external website, participant web
application and administrative web application. MVP Online
officially launched on October 4,
2019. Learn more about MVP here.
About Perspecta Inc.
At Perspecta (NYSE: PRSP), we question, we seek and we solve.
Perspecta brings a diverse set of capabilities to our U.S.
government customers in defense, intelligence, civilian, health
care and state and local markets. Our 270+ issued, licensed and
pending patents are more than just pieces of paper, they tell the
story of our innovation. With offerings in mission services,
digital transformation and enterprise operations, our team of
14,000 engineers, analysts, investigators and architects work
tirelessly to not only execute the mission, but build and support
the backbone that enables it. Perspecta was formed to take on big
challenges. We are an engine for growth and success and we enable
our customers to build a better nation. For more information
about Perspecta, visit perspecta.com.
About PRA Health Sciences
PRA (NASDAQ: PRAH) is a full-service global contract research
organization, providing a broad range of product development and
data solution services to pharmaceutical and biotechnology
companies around the world. PRA's integrated services include data
management, statistical analysis, clinical trial management, and
regulatory and drug development consulting. PRA's global
operations span more than 90 countries across North America, Europe, Asia,
Latin America, South Africa, Australia and the Middle East, and more than 16,000 employees.
Since 2000, PRA has participated in more than 3,800 clinical
trials. In addition, PRA has participated in the pivotal or
supportive trials that led to U.S. Food and Drug Administration or
international regulatory approval of more than 85 products. To
learn more about PRA, please visit www.prahs.com.
This press release may contain forward-looking statements.
These forward-looking statements are made on the basis of the
current beliefs, expectations and assumptions of the management of
Perspecta and are subject to significant risks and uncertainty.
Readers are cautioned not to place undue reliance on any such
forward-looking statements. All such forward-looking statements
speak only as of the date they are made, and Perspecta undertakes
no obligation to update or revise these statements, whether as a
result of new information, future events or otherwise. Although
Perspecta believes that the expectations reflected in these
forward-looking statements are reasonable, these statements involve
a variety of risks and uncertainties that may cause actual results
to differ materially from what may be expressed or implied in these
forward-looking statements.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/perspecta-and-pra-health-sciences-complete-successful-modernization-of-million-veteran-program-for-us-department-of-veterans-affairs-300982645.html
SOURCE Perspecta